Rational Design of Novel Allosteric EYA2 Inhibitors as Potential Therapeutics for Multiple Brain Cancers
Journal Article
Overview
publication date
- September 16, 2024
has subject area
- Allosteric Regulation
- Antineoplastic Agents
- Biochemical Phenomena - Molecular Structure
- Biochemical Phenomena - Structure-Activity Relationship
- Biological Science Disciplines - Drug Design
- Brain Diseases - Brain Neoplasms
- Cell Line - Cell Line, Tumor
- Cell Physiological Phenomena - Cell Proliferation
- Chemical Phenomena - Molecular Structure
- Chemistry - Drug Design
- Diagnostic Techniques and Procedures - Drug Screening Assays, Antitumor
- Enzyme Inhibitors
- Growth - Cell Proliferation
- Humans
- Investigative Techniques - Drug Design
- Investigative Techniques - Drug Screening Assays, Antitumor
- Investigative Techniques - Drug Screening Assays, Antitumor
- Investigative Techniques - Drug Screening Assays, Antitumor
- Neoplasms by Site - Brain Neoplasms
- Nervous System Diseases - Brain Neoplasms
- Nuclear Proteins
- Peptides - Intracellular Signaling Peptides and Proteins
- Pharmacological Phenomena - Dose-Response Relationship, Drug
- Pharmacological Phenomena - Structure-Activity Relationship
- Protein Tyrosine Phosphatases
- Proteins - Intracellular Signaling Peptides and Proteins
- Toxicological Phenomena - Dose-Response Relationship, Drug
- Tumor Cells, Cultured - Cell Line, Tumor
has restriction
- closed
Date in CU Experts
- June 14, 2024 6:50 AM
Full Author List
- Gardner L; Rossi J; Armstrong B; Muse M; LaVeck A; Blevins MA; Zhang L; Ford HL; Zhao R; Wang X
author count
- 10
citation count
- 0
published in
Other Profiles
International Standard Serial Number (ISSN)
- 1860-7179
Electronic International Standard Serial Number (EISSN)
- 1860-7187
Digital Object Identifier (DOI)
Additional Document Info
volume
- 19
issue
- 18